N-glycomic changes in serum proteins during human aging

Rejuvenation Research

Volumn 10, Issue 4, 2007, Pages 521-531

  Vanhooren, Valerie ^a,b   Desmyter, Liesbeth ^a,b   Liu, Xue En ^a,b   Cardelli, Maurizio ^c   Franceschi, Claudio ^d   Federico, Antonio ^e   Libert, Claude ^a,b   Laroy, Wouter ^a,b   Dewaele, Sylviane ^a,b   Contreras, Roland ^a,b   Chen, Cuiying ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c INRCA   (Italy)

^d Department of Experimental Pathology ^*  (Italy)

^e UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCAN DERIVATIVE; GLYCOPROTEIN; PLASMA PROTEIN;

ADULT; AGED; AGING; ARTICLE; B LYMPHOCYTE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; WERNER SYNDROME;

AGED; AGED, 80 AND OVER; AGING; BLOOD PROTEINS; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULINS; MALE; POLYSACCHARIDES; WERNER SYNDROME;

EID: 37549057294     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2007.0556     Document Type: Article

References (44)

1. Martin I, Grotewiel MS. Oxidative damage and age-related functional declines. Mech Ageing Dev 2006;127:411-423.
2. Lenaz G, Baracca A, Fato R, Genova ML, Solaini G. New insights into structure and function of mitochondria and their role in aging and disease. Antioxid Redox Signal 2006;8:417-437.
3. Candore G, Colonna-Romano G, Balistreri CR, Di Carlo D, Grimaldi MP, Listi F, Nuzzo D, Vasto S, Lio D, Caruso C. Biology of longevity: role of the innate immune system. Rejuv Res 2006;9:143-148.
4. Boehm M, Slack FJ. MicroRNA Control of lifespan and metabolism. Cell Cycle 2006;5:837-840.
5. Lautenschlager NT, Almeida OP. Physical activity and cognition in old age. Curr Opin Psychiatry 2006;19:190-193.
6. Prohovnik I, Perl DP, Davis KL, Libow L. Lesser G, Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology 2006;66:49-55.
7. Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest 2005;28:73-79.
8. Srikanth V, Saling MM, Thrift AG, Donnan GA. Cerebrovascular disease and dementia. Drugs Today (Barc) 2005;41:815-825.
9. Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:65-75.
10. Hefti FF, Bales R. Regulatory issues in aging pharmacology. Aging Cell 2006;5:3-8.
11. Butler RN, Sprott R, Warner H. Bland J. Feuers R, Forster M. Fillit H. Harman SM, Hewitt M, Hyman M, et al. Biomarkers of aging: from primitive organisms to humans. J Gerontol A Biol Sci Med Sci 2004;59:B560-B567.
12. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006;52:601-623.
13. Spindler SR. Use of microarray biomarkers to identify longevity therapeutics. Aging Cell 2006;5:39-50.
14. Dimri GP. The search for biomarkers of aging: next stop INK4a/ARF locus. Sci Aging Knowledge Environ 2004;pe40.
15. Kukuruzinska MA, Lennon K. Protein N-glycosylation: molecular genetics and functional significance. Crit Rev Oral Biol Med 1998;9:415-448.
16. Raman R, Raguram S, Venkataraman G, Paulson JC, Sasisekharan R. Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods 2005;2:817-824.
17. Freeze HH, Aebi M. Altered glycan structures: the molecular basis of congenital disorders of glycosylation. Curr Opin Struct Biol 2005;15:490-498.
18. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988;167:1731-1736.
19. Laroy W, Contreras R, Callewaert N. Glycome mapping on DNA sequencing equipment. Nat Protoc 2006;1:397-405.
20. Raju TS, Briggs JB, Borge SM, Jones AJ. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 2000;10: 477-486.
21. Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003;31:457-461.
22. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000;908:244-254.
23. Bohr VA. Deficient DNA repair in the human progeroid disorder, Werner syndrome. Mutat Res 2005;577:252-259.
24. Nehlin JO, Skovgaard GL, Bohr VA. The Werner syndrome: a model for the study of human aging. Ann N Y Acad Sci 2000;908:167-179.
25. Lee JW, Harrigan J, Opresko PL, Bohr VA. Pathways and functions of the Werner syndrome protein. Mech Ageing Dev 2005;126:79-86.
26. Comai L, Li B. The Werner syndrome protein at the crossroads of DNA repair and apoptosis. Mech Ageing Dev 2004;125:521-528.
27. Opresko PL, Cheng WH, von Kobbe C, Harrigan JA, Bohr VA. Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 2003;24:791-802.
28. Callewaert N, Geysens S, Molemans F, Contreras R. Ultrasensitive profiling and sequencing of N-linked oligosaccharides using standard DNA-sequencing equipment. Glycobiology 2001;11:275-281.
29. Franceschi C, Motta L. Valensin S, Rapisarda R, Franzone A, Berardelli M, Motta M, Monti D, Bonafè M, Ferrucci L, et al. Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) 2000;12:77-84.
30. Deiana L, Ferrucci L, Pes GM, Carru C, Delitaia G, Ganau A, Mariotti S, Nieddu A, Pettinato S, Putzu P, et al. AKEntAnnos. The Sardinia Study of Extreme Longevity. Aging (Milano) 1999;11:142-149.
31. Yarema KJ, Bertozzi CR. Characterizing glycosylation pathways. Genome Biol 2001;2:REVIEWS0004.
32. Lee BY, Han JA, Im JS, Morrone A, Johung K. Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES. Senescenceassociated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 2006;5:187-195.
33. Toussaint O, et al. Stress-induced premature senescence: essence of life, evolution, stress, and aging. Ann N Y Acad Sci 2000;908:85-98.
34. Kobata A. Glycobiology in the field of aging research - introduction to glycogerontology. Biochimie 2003;85:13-24.
35. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science 2001;291:2370-2376.
36. Tsuchiya N, Endo T, Shiota M, Kochibe N, Ito K, Kobata A. Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis. Clin Immunol Immunopathol 1994; 70:47-50.
37. Martin K, Talukder R, Hay FC, Axford JS. Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis. J Rheumatol 2001;28: 1531-1536.
38. Field MC, Amatayakul-Chantler S, Rademacher TW, Rudd PM, Dwek RA. Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J 1994;299(pt 1):261-275.
39. Matei L. Plasma proteins glycosylation and its alteration in disease. Rom J Intern Med 1997;35:3-11.
40. Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004;10: 429-434.
41. Liu X, Desmyter L, Gao C, Laroy W, Dewaele S, Vanhooren V, Wang L, Zhuang H, Callewaert N, Libert C, Contreras R, Chen C. N-glycomics changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007;46: 1426-1435.
42. De Stefano N, Dotti MT, Battisti C, Sicurelli F, Stromillo ML, Mortilla M, Federico A. MR evidence of structural and metabolic changes in brains of patients with Werner's syndrome. J Neurol 2003;250: 1169-1173.
43. Malandrini A, Dotti MT, Villanova M, Battisti C, Federico A. Neurological involvement in Werner's syndrome: clinical and biopsy study of a familial case. Eur Neurol 2000;44:187-189.
44. Battisti C, Formichi P, Tripodi SA, Morbini G, Tose P, Federico A. Enhanced 2-deoxy-D-ribose-induced-apoptosis, a phenotype of lymphocytes from old donors, is not observed in the Werner syndrome. Exp Gerontol 2000;35:605-612.